← Back to Search

Implementing a CO-OP Group in the Day Rehab Setting: A Pilot Study.

Chicago, IL

N/A

Waitlist Available

Led By Sarah Zera, OTD

Research Sponsored by Shirley Ryan AbilityLab

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Current patient in day rehabilitation admitted for rehabilitation from stroke, able to communicate sufficiently to complete the COPM, able to identify two goals on the COPM, English speaking, receiving occupational therapy services, over 18 years of age.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline at 8 weeks.

Awards & highlights

No Placebo-Only Group

Summary

This is pilot study will examine the effectiveness of a group curriculum developed from the CO-OP approach. This study has two aims, the first is to standardize the group curriculum and the second is to compare the data from the group receiving CO-OP group curriculum to the control group. Primary methods will include a standardized observation of occupational performance, an semi-structured interview measuring performance and satisfaction of occupational performance, a survey of community participation, and a focus group.

See full description

Eligible Conditions

Stroke

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline at 8 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline at 8 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 8 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Assessment of Motor and Process Skills

Canadian Occupational Performance Measure

The Community Participation Index

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Allocated to interventionExperimental Treatment1 Intervention

Participants will participate in a one on one session to complete their COPM and set their goal for the group. Participants will participate in 6 group sessions focusing on the CO-OP approach.

Group II: Allocated to controlActive Control1 Intervention

The control group will receive "usual care" occupational therapy including a mix of individual sessions and occupational therapy groups that do not include the CO-OP group.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CO-OP Group

2020

N/A

~30

0 / 1Eligibility criteria met